Chevron Is Taking a $3 Billion to $4 Billion Loss on Hess Midstream. Should You Buy the Stock Anyway?

Chevron (CVX) is booking a $3 billion to $4 billion write-off tied to its Hess Midstream (HESM) deal, a charge stemming from portfolio integration after its 2025 Hess acquisition.

The headline hit is a near-term cost. The offset is operational: the deal is expected to cut CVX's midstream costs in the Bakken region by up to 50%. That figure is the core of the bull case, since lower midstream expense in a single basin feeds directly into long-term profitability, per the source.

The balance sheet is positioned to absorb the charge. CVX carries a strong balance sheet, 38 consecutive years of dividend increases, and a 3.1% yield. Those are the anchors for income-focused holders weighing whether a one-time write-off changes the thesis.

Interpretation: a write-off of this size is an accounting event tied to integration rather than a signal about the Bakken cost savings, which the source frames as the lasting outcome. The market question is whether the up-to-50% cost reduction materializes at a scale that justifies the $3-4 billion hit. HESM, as the midstream entity named in the deal, sits at the center of that cost story.